Johnson & Johnson (JNJ): Rep. Lloyd Doggett (TX37) disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

29 days

Disclosure lag

Traded

Jun 4, 2024

Disclosed

Jul 3, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 14, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Nov 10, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Mar 5, 2024Congress · 2 peopleMembers of Congress: 2 purchases
4. Jun 4, 2024 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

1. Jun 4, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Jun 13, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
3. Jun 21, 2024CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
4. Jul 1, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
5. Jul 2, 2024Congress · 1 personMembers of Congress: 2 purchases
6. Jul 3, 2024Congress · 1 personMembers of Congress: 2 sales
7. Jul 16, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
8. Aug 2, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
9. Aug 5, 2024FDARecall: ImpellaCP SmartAssistSetAPAC, Delo1895; Product Code: 1000302;
10. Aug 5, 2024FDARecall: Impella CP Pump 371 Set, Clinical Trial; Product Code: 0048-0040;
11. Aug 5, 2024FDARecall: Impella 5.5 SmartAssist Set, JP; Product Code: 1000211;
12. Aug 5, 2024FDARecall: Pump 381 Pump Set (US); Product Code: 1000080;
13. Aug 6, 2024FDAFDA device clearance: Abiomed 14Fr Low Profile Introducer Kit
14. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
15. Aug 19, 2024FDAFDA drug approval: Rybrevant
16. Aug 19, 2024FDAFDA drug approval: Lazcluze
17. Sep 4, 2024CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
18. Sep 6, 2024FDAFDA device clearance: MENTOR™ MemoryGel™ Enhance Single Use Gel Sizer
19. Sep 9, 2024FDAFDA device clearance: TriALTIS™ Spine System
20. Sep 11, 2024FDAFDA drug approval: Tremfya

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Lloyd Doggett (TX37)

• House Clerk periodic transaction report at Home Depot (HD)Oct 5, 2026
• House Clerk periodic transaction report at IBM (IBM)Oct 5, 2026
• House Clerk periodic transaction report at Johnson & Johnson (JNJ)Oct 5, 2026
• House Clerk periodic transaction report at PPG Industries (PPG)Oct 5, 2026
• House Clerk periodic transaction report at Procter & Gamble (PG)Sep 8, 2026

The full history of Rep. Lloyd Doggett (TX37) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 24, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026

Everything OQRO holds on this company is on its JNJ page.